Company news
Bioceltix Sa (GPW:BCX) news
Bioceltix Sa news releases on 6ix. Latest, Jun 10, 2026: Bioceltix Receives Permit For Biological Veterinary Drugs Facility
Press releases & updates
Bioceltix Receives Permit For Biological Veterinary Drugs Facility
June 10, 2026
BCX: Strong cash position, regulatory progress, and major investments mark Q1 2026 pre-commercial phase
May 29, 2026
BCX: Advanced cell therapy pipeline, secured funding, and strengthened readiness for commercialization
April 28, 2026
Bioceltix Signs Advisory Agreement For FDA Regulatory Support
April 14, 2026
BCX: Pioneering stem cell therapies for pets, with proven efficacy and major market expansion plans
March 31, 2026
Bioceltix Gets GMP Certificate For Wroclaw Veterinary Medicine Facility
February 18, 2026
Bioceltix Q3 Net Loss At 4.4 Mln Zlotys
December 1, 2025
TFI PZU Funds Up Stake In Bioceltix To 15.75%
October 22, 2025
Bioceltix Says EGM To Vote On Increase of Share Capital Via Issue Of O Series Shares
October 20, 2025
Bioceltix's Shareholders Complete ABB Process
October 15, 2025
Bioceltix Shareholders Start ABB For Sale Of Up To 577,785 Company Shares
October 13, 2025